Skip to main content
Premium Trial:

Request an Annual Quote

10x Genomics Prices Upsized $440M Public Offering

NEW YORK – Single-cell and spatial molecular analysis firm 10x Genomics announced on Friday the pricing of an upsized underwritten public offering of Class A common stock at $110 per share, before underwriting discounts and commissions.

The Pleasanton, California-based firm is now offering 4 million shares, plus an option for the underwriters to purchase an additional 600,000 shares at the public offering price. Initially, the company said it planned to offer 3.5 million shares plus an underwriters' option of 500,000 shares. The firm expects the offering to close on Sept. 15, 2020.

JP Morgan, Bank of America, and Cowen and Company are underwriters for the offering. Stifel and William Blair are acting as co-managers.

The firm went public a year ago, raising $410.8 million in net proceeds.

In Friday morning trade on the Nasdaq, shares of 10x Genomics were up nearly 3 percent at $116.75.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.